Literature DB >> 27003994

Astragalus polysaccharide attenuates rat experimental colitis by inducing regulatory T cells in intestinal Peyer's patches.

Hai-Mei Zhao1, Yan Wang1, Xiao-Ying Huang1, Min-Fang Huang1, Rong Xu1, Hai-Yang Yue1, Bu-Gao Zhou1, Hong-Yan Huang1, Qi-Meng Sun1, Duan-Yong Liu1.   

Abstract

AIM: To explore probable mechanism underlying the therapeutic effect of Astragalus polysaccharide (APS) against experimental colitis.
METHODS: Thirty-two Sprague-Dawley rats were randomly divided into four groups. Colitis was induced with 2, 4, 6-trinitrobenzene sulfonic acid (TNBS). The rats with colitis were treated with 400 mg/kg of APS for 7 d. The therapeutic effect was evaluated by colonic weight, weight index of the colon, colonic length, and macroscopic and histological scores. The levels of regulatory T (Treg) cells in Peyer's patches were measured by flow cytometry, and cytokines in colonic tissue homogenates were analyzed using enzyme-linked immunosorbent assay. The expression of related orphan receptor-γt (ROR-γt), IL-23 and STAT-5a was measured by Western blot.
RESULTS: After 7-d treatment with APS, the weight index of the colon, colonic weight, macroscopical and histological scores were decreased, while the colonic length was increased compared with the model group. The expression of interleukin (IL)-2, IL-6, IL-17, IL-23 and ROR-γt in the colonic tissues was down-regulated, but Treg cells in Peyer's patches, TGF-β and STAT5a in the colonic tissues were up-regulated.
CONCLUSION: APS effectively ameliorates TNBS-induced experimental colitis in rats, probably through restoring the number of Treg cells, and inhibiting IL-17 levels in Peyer's patches.

Entities:  

Keywords:  Astragalus polysaccharide; Colitis; Interleukin-17; Regulatory T cells

Mesh:

Substances:

Year:  2016        PMID: 27003994      PMCID: PMC4789992          DOI: 10.3748/wjg.v22.i11.3175

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  52 in total

1.  T(H)-17 differentiation: of mice and men.

Authors:  Arian Laurence; John J O'Shea
Journal:  Nat Immunol       Date:  2007-09       Impact factor: 25.606

2.  RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice.

Authors:  Maria Martin; Rebecca K Kesselring; Balam Saidou; Stefan M Brunner; Gabriela Schiechl; Verena F Mouris; Anja K Wege; Petra Rümmele; Hans J Schlitt; Edward K Geissler; Stefan Fichtner-Feigl
Journal:  Eur J Immunol       Date:  2015-05-15       Impact factor: 5.532

3.  Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis.

Authors:  Joshua-Ka-Shun Ko; Flora-Ying-Lee Lam; Andrew-Pok-Lap Cheung
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

4.  Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity.

Authors:  Nathalie Holmén; Anna Lundgren; Samuel Lundin; Ann-Marie Bergin; Anna Rudin; Henrik Sjövall; Lena Ohman
Journal:  Inflamm Bowel Dis       Date:  2006-06       Impact factor: 5.325

5.  TGF-beta promotes Th17 cell development through inhibition of SOCS3.

Authors:  Hongwei Qin; Lanfang Wang; Ting Feng; Charles O Elson; Sandrine A Niyongere; Sun Jung Lee; Stephanie L Reynolds; Casey T Weaver; Kevin Roarty; Rosa Serra; Etty N Benveniste; Yingzi Cong
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

6.  Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice.

Authors:  Xiaogang Du; Bing Zhao; Jinyao Li; Xiaohan Cao; Mingkun Diao; Haibo Feng; Xiaobing Chen; Zhiyu Chen; Xianyin Zeng
Journal:  Int Immunopharmacol       Date:  2012-09-21       Impact factor: 4.932

7.  Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid.

Authors:  Daniel Mucida; Yunji Park; Gisen Kim; Olga Turovskaya; Iain Scott; Mitchell Kronenberg; Hilde Cheroutre
Journal:  Science       Date:  2007-06-14       Impact factor: 47.728

Review 8.  Regulatory T cells in inflammatory bowel disease.

Authors:  Elisa K Boden; Scott B Snapper
Journal:  Curr Opin Gastroenterol       Date:  2008-11       Impact factor: 3.287

9.  TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.

Authors:  Liang Zhou; Jared E Lopes; Mark M W Chong; Ivaylo I Ivanov; Roy Min; Gabriel D Victora; Yuelei Shen; Jianguang Du; Yuri P Rubtsov; Alexander Y Rudensky; Steven F Ziegler; Dan R Littman
Journal:  Nature       Date:  2008-03-26       Impact factor: 49.962

10.  Huang Qi Jian Zhong Pellet Attenuates TNBS-Induced Colitis in Rats via Mechanisms Involving Improvement of Energy Metabolism.

Authors:  Duan-Yong Liu; Chun-Shui Pan; Yu-Ying Liu; Xiao-Hong Wei; Chang-Man Zhou; Kai Sun; Ke He; Chong Li; Li Yan; Jing-Yu Fan; Chuan-She Wang; Toshifumi Hibi; Hong-Ning Liu; Jing-Yan Han
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-06       Impact factor: 2.629

View more
  12 in total

Review 1.  The Function of Natural Polysaccharides in the Treatment of Ulcerative Colitis.

Authors:  Yafei Guo; Yang Li; Qiang Cao; Leilei Ye; Junmei Wang; Mei Guo
Journal:  Front Pharmacol       Date:  2022-07-04       Impact factor: 5.988

2.  Therapeutic Effect of Astragalus Polysaccharides on Hepatocellular Carcinoma H22-Bearing Mice.

Authors:  Xiaoyu Lai; Weibiao Xia; Jing Wei; Xinghong Ding
Journal:  Dose Response       Date:  2017-01-03       Impact factor: 2.658

3.  Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 Signaling Pathway.

Authors:  Hualiang Jin; Limin Wang; Bei Li; Cui Cai; Jian Ye; Junbo Xia; Shenglin Ma
Journal:  Evid Based Complement Alternat Med       Date:  2017-10-25       Impact factor: 2.629

4.  Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis.

Authors:  Shuang Chen; Meng-Bei Xu; Xiao-Li Zhou; Pei-Qing Rong; Ting-Yu Jin; Guo-Qing Zheng
Journal:  Front Pharmacol       Date:  2018-08-30       Impact factor: 5.810

5.  Effect of Astragalus membranaceus Oral Solution on Lifespan and Learning and Memory Ability of Honey Bees.

Authors:  Tao Hong; Long-Xue Li; Xiao-Ping Han; Jing-Liang Shi; Cai-Yun Dan; Zhi-Yong Liu; Xiao-Bo Wu
Journal:  Biomed Res Int       Date:  2020-04-11       Impact factor: 3.411

6.  Effects of Dietary Astragalus Polysaccharide Supplementation on the Th17/Treg Balance and the Gut Microbiota of Broiler Chickens Challenged With Necrotic Enteritis.

Authors:  Bochen Song; Peng Li; Shaojia Yan; Yan Liu; Mingkun Gao; Huiyuan Lv; Zengpeng Lv; Yuming Guo
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

7.  Albuca Bracteata Polysaccharides Attenuate AOM/DSS Induced Colon Tumorigenesis via Regulating Oxidative Stress, Inflammation and Gut Microbiota in Mice.

Authors:  Ziyan Qin; Xinyu Yuan; Jian Liu; Zhuqing Shi; Leipeng Cao; Lexuan Yang; Kai Wu; Yongliang Lou; Haibin Tong; Lei Jiang; Jimei Du
Journal:  Front Pharmacol       Date:  2022-02-21       Impact factor: 5.810

8.  The "whole ingredients extract" of Astragali Radix improves the symptoms of dextran sulfate sodium-induced ulcerative colitis in mice through systemic immunomodulation.

Authors:  Ke-Gang Linghu; Qiushuo Ma; Shi-Hang Xiong; Mingming Zhao; Qiling Chen; Wen Xu; Meiwan Chen; Jian-Ye Zhang; Yuanjia Hu; Wei Xu; Hua Yu
Journal:  Chin Med       Date:  2022-09-15       Impact factor: 4.546

Review 9.  A centric view of JAK/STAT5 in intestinal homeostasis, infection, and inflammation.

Authors:  Marta Surbek; William Tse; Richard Moriggl; Xiaonan Han
Journal:  Cytokine       Date:  2021-01-19       Impact factor: 3.861

10.  Astragalus membranaceus (Fisch.) Bunge repairs intestinal mucosal injury induced by LPS in mice.

Authors:  Yizhe Cui; Qiuju Wang; Rui Sun; Li Guo; Mengzhu Wang; Junfeng Jia; Chuang Xu; Rui Wu
Journal:  BMC Complement Altern Med       Date:  2018-08-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.